{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:44:32Z","timestamp":1794620672079,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Research and Innovation Fund"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2022R1I1A1A01068782"],"award-info":[{"award-number":["NRF- 2022R1I1A1A01068782"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23626-3","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:28:06Z","timestamp":1763134086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combination of THU\/ALK-5i exhibits profound anti-MASH activity through suppression of lipogenesis and fibrogenesis"],"prefix":"10.1038","volume":"15","author":[{"given":"Kampeebhorn","family":"Boonloh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Ho","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Bin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon Hee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"23626_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1055\/a-1378-4679","volume":"130","author":"C Labenz","year":"2022","unstructured":"Labenz, C., Kostev, K., Alqahtani, S. A., Galle, P. R. & Schattenberg, J. M. Impact of non-alcoholic fatty liver disease on metabolic comorbidities in type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes. 130, 172\u2013177. https:\/\/doi.org\/10.1055\/a-1378-4679 (2022).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"23626_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels, S. et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord. 22, 63. https:\/\/doi.org\/10.1186\/s12902-022-00980-1 (2022).","journal-title":"BMC Endocr. Disord"},{"key":"23626_CR3","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1159\/000375353","volume":"33","author":"S Traussnigg","year":"2015","unstructured":"Traussnigg, S. et al. Challenges and management of liver cirrhosis: practical issues in the therapy of patients with cirrhosis due to NAFLD and NASH. Dig. Dis. 33, 598\u2013607. https:\/\/doi.org\/10.1159\/000375353 (2015).","journal-title":"Dig. Dis."},{"key":"23626_CR4","doi-asserted-by":"publisher","unstructured":"Tanase, D. et al. (ed, M.) The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J. Diabetes Res. 2020 3920196 https:\/\/doi.org\/10.1155\/2020\/3920196 (2020).","DOI":"10.1155\/2020\/3920196"},{"key":"23626_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/icb.2011.112","volume":"90","author":"SZ Hasnain","year":"2012","unstructured":"Hasnain, S. Z., Lourie, R., Das, I., Chen, A. C. & McGuckin, M. A. The interplay between Endoplasmic reticulum stress and inflammation. Immunol. Cell. Biol. 90, 260\u2013270. https:\/\/doi.org\/10.1038\/icb.2011.112 (2012).","journal-title":"Immunol. Cell. Biol."},{"key":"23626_CR6","doi-asserted-by":"publisher","unstructured":"Kim, J. Y. et al. ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P. Cell 175, 133\u2013145 e115, (2018). https:\/\/doi.org\/10.1016\/j.cell.2018.08.020","DOI":"10.1016\/j.cell.2018.08.020"},{"key":"23626_CR7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/s1097-2765(00)00133-7","volume":"6","author":"J Ye","year":"2000","unstructured":"Ye, J. et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell. 6, 1355\u20131364. https:\/\/doi.org\/10.1016\/s1097-2765(00)00133-7 (2000).","journal-title":"Mol. Cell."},{"key":"23626_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/JME-19-0207","volume":"64","author":"T Xiao","year":"2020","unstructured":"Xiao, T. et al. Mitochondrial stress protein HSP60 regulates ER stress-induced hepatic lipogenesis. J. Mol. Endocrinol. 64, 67\u201375. https:\/\/doi.org\/10.1530\/JME-19-0207 (2020).","journal-title":"J. Mol. Endocrinol."},{"key":"23626_CR9","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.mad.2021.111572","volume":"199","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Hepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives. Mech. Ageing Dev. 199, 111572. https:\/\/doi.org\/10.1016\/j.mad.2021.111572 (2021).","journal-title":"Mech. Ageing Dev."},{"key":"23626_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T. & Brenner, D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 18, 151\u2013166. https:\/\/doi.org\/10.1038\/s41575-020-00372-7 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"23626_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi, T., Friedman, S. L. & Hoshida, Y. Hepatic stellate cells as key target in liver fibrosis. Adv. Drug Deliv Rev. 121, 27\u201342. https:\/\/doi.org\/10.1016\/j.addr.2017.05.007 (2017).","journal-title":"Adv. Drug Deliv Rev."},{"key":"23626_CR12","doi-asserted-by":"publisher","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","volume":"176","author":"S Kumar","year":"2021","unstructured":"Kumar, S., Duan, Q., Wu, R., Harris, E. N. & Su, Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv. Drug Deliv Rev. 176, 113869. https:\/\/doi.org\/10.1016\/j.addr.2021.113869 (2021).","journal-title":"Adv. Drug Deliv Rev."},{"key":"23626_CR13","doi-asserted-by":"publisher","unstructured":"Dewidar, B., Meyer, C., Dooley, S. & Meindl-Beinker, A. N. TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells 8 https:\/\/doi.org\/10.3390\/cells8111419 (2019).","DOI":"10.3390\/cells8111419"},{"key":"23626_CR14","doi-asserted-by":"publisher","unstructured":"Morikawa, M., Derynck, R. & Miyazono, K. TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect. Biol. 8 https:\/\/doi.org\/10.1101\/cshperspect.a021873 (2016).","DOI":"10.1101\/cshperspect.a021873"},{"key":"23626_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"HH Hu","year":"2018","unstructured":"Hu, H. H. et al. New insights into TGF-beta\/Smad signaling in tissue fibrosis. Chem. Biol. Interact. 292, 76\u201383. https:\/\/doi.org\/10.1016\/j.cbi.2018.07.008 (2018).","journal-title":"Chem. Biol. Interact."},{"key":"23626_CR16","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.2174\/138920111798808257","volume":"12","author":"LE Ling","year":"2011","unstructured":"Ling, L. E. & Lee, W. C. Tgf-beta type I receptor (Alk5) kinase inhibitors in oncology. Curr. Pharm. Biotechnol. 12, 2190\u20132202. https:\/\/doi.org\/10.2174\/138920111798808257 (2011).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"23626_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3109\/10799893.2015.1024852","volume":"35","author":"A Lin","year":"2015","unstructured":"Lin, A., Cai, Z., Hu, G. & Li, Q. Identification of ALK5 inhibitor via structure-based virtual screening and ADMET prediction. J. Recept Signal. Transduct. Res. 35, 559\u2013564. https:\/\/doi.org\/10.3109\/10799893.2015.1024852 (2015).","journal-title":"J. Recept Signal. Transduct. Res."},{"key":"23626_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/sj.ki.5001775","volume":"70","author":"JA Moon","year":"2006","unstructured":"Moon, J. A., Kim, H. T., Cho, I. S., Sheen, Y. Y. & Kim, D. K. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int. 70, 1234\u20131243. https:\/\/doi.org\/10.1038\/sj.ki.5001775 (2006).","journal-title":"Kidney Int."},{"key":"23626_CR19","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s11010-022-04447-8","volume":"477","author":"P Joshi","year":"2022","unstructured":"Joshi, P. et al. Role of Curcumin in ameliorating hypertension and associated conditions: a mechanistic insight. Mol. Cell. Biochem. 477, 2359\u20132385. https:\/\/doi.org\/10.1007\/s11010-022-04447-8 (2022).","journal-title":"Mol. Cell. Biochem."},{"key":"23626_CR20","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.ejca.2011.07.007","volume":"47","author":"CY Park","year":"2011","unstructured":"Park, C. Y. et al. EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung. Eur. J. Cancer. 47, 2642\u20132653. https:\/\/doi.org\/10.1016\/j.ejca.2011.07.007 (2011).","journal-title":"Eur. J. Cancer"},{"key":"23626_CR21","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00018-014-1798-6","volume":"72","author":"SA Park","year":"2015","unstructured":"Park, S. A. et al. EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-beta\/Smad and ROS signaling. Cell. Mol. Life Sci. 72, 2023\u20132039. https:\/\/doi.org\/10.1007\/s00018-014-1798-6 (2015).","journal-title":"Cell. Mol. Life Sci."},{"key":"23626_CR22","doi-asserted-by":"publisher","first-page":"16104","DOI":"10.1038\/s41598-022-20050-9","volume":"12","author":"J Park","year":"2022","unstructured":"Park, J., Choi, J., Cho, I. & Sheen, Y. Y. Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-beta\/ALK5 inhibitor. Sci. Rep. 12, 16104. https:\/\/doi.org\/10.1038\/s41598-022-20050-9 (2022).","journal-title":"Sci. Rep."},{"key":"23626_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","volume":"27","author":"MH Pan","year":"1999","unstructured":"Pan, M. H., Huang, T. M. & Lin, J. K. Biotransformation of Curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 27, 486\u2013494 (1999).","journal-title":"Drug Metab. Dispos."},{"key":"23626_CR24","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/jn\/131.8.2090","volume":"131","author":"K Okada","year":"2001","unstructured":"Okada, K. et al. Curcumin and especially Tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J. Nutr. 131, 2090\u20132095. https:\/\/doi.org\/10.1093\/jn\/131.8.2090 (2001).","journal-title":"J. Nutr."},{"key":"23626_CR25","doi-asserted-by":"publisher","unstructured":"Zhang, L. et al. Tetrahydrocurcumin-related vascular protection: an overview of the findings from animal disease models. Molecules 27 https:\/\/doi.org\/10.3390\/molecules27165100 (2022).","DOI":"10.3390\/molecules27165100"},{"key":"23626_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3803\/EnM.2021.988","volume":"36","author":"W Sangartit","year":"2021","unstructured":"Sangartit, W. et al. Tetrahydrocurcumin ameliorates kidney injury and high systolic blood pressure in high-fat diet-induced type 2 diabetic mice. Endocrinol. Metab. (Seoul). 36, 810\u2013822. https:\/\/doi.org\/10.3803\/EnM.2021.988 (2021).","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"23626_CR27","doi-asserted-by":"publisher","first-page":"12685","DOI":"10.1021\/acs.jafc.8b04624","volume":"66","author":"MH Pan","year":"2018","unstructured":"Pan, M. H. et al. Attenuation by Tetrahydrocurcumin of adiposity and hepatic steatosis in mice with high-fat-diet-induced obesity. J. Agric. Food Chem. 66, 12685\u201312695. https:\/\/doi.org\/10.1021\/acs.jafc.8b04624 (2018).","journal-title":"J. Agric. Food Chem."},{"key":"23626_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/08860220701540326","volume":"29","author":"L Pari","year":"2007","unstructured":"Pari, L. & Murugan, P. Antihyperlipidemic effect of Curcumin and Tetrahydrocurcumin in experimental type 2 diabetic rats. Ren. Fail. 29, 881\u2013889. https:\/\/doi.org\/10.1080\/08860220701540326 (2007).","journal-title":"Ren. Fail."},{"key":"23626_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1515\/jbcpp.2005.16.4.257","volume":"16","author":"L Pari","year":"2005","unstructured":"Pari, L. & Murugan, P. Effect of Tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J. Basic. Clin. Physiol. Pharmacol. 16, 257\u2013274. https:\/\/doi.org\/10.1515\/jbcpp.2005.16.4.257 (2005).","journal-title":"J. Basic. Clin. Physiol. Pharmacol."},{"key":"23626_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3389\/fphar.2018.01181","volume":"9","author":"ZB Zhang","year":"2018","unstructured":"Zhang, Z. B. et al. Curcumin\u2019s metabolites, Tetrahydrocurcumin and octahydrocurcumin, possess superior anti-inflammatory effects in vivo through suppression of TAK1-NF-kappaB pathway. Front. Pharmacol. 9, 1181. https:\/\/doi.org\/10.3389\/fphar.2018.01181 (2018).","journal-title":"Front. Pharmacol."},{"key":"23626_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jhep.2015.02.041","volume":"62","author":"V Ratziu","year":"2015","unstructured":"Ratziu, V., Goodman, Z. & Sanyal, A. Current efforts and trends in the treatment of NASH. J. Hepatol. 62, 65\u201375. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.041 (2015).","journal-title":"J. Hepatol."},{"issue":"Suppl 1","key":"23626_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/liv.13302","volume":"37","author":"AM Oseini","year":"2017","unstructured":"Oseini, A. M. & Sanyal, A. J. Therapies in non-alcoholic steatohepatitis (NASH). Liver Int. 37 (Suppl 1), 97\u2013103. https:\/\/doi.org\/10.1111\/liv.13302 (2017).","journal-title":"Liver Int."},{"key":"23626_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","volume":"1061","author":"GC Farrell","year":"2018","unstructured":"Farrell, G. C., Haczeyni, F. & Chitturi, S. Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease. Adv. Exp. Med. Biol. 1061, 19\u201344. https:\/\/doi.org\/10.1007\/978-981-10-8684-7_3 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"23626_CR34","doi-asserted-by":"publisher","unstructured":"Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S. & Marra, F. Cellular and molecular mechanisms underlying liver fibrosis regression. Cells 10 https:\/\/doi.org\/10.3390\/cells10102759 (2021).","DOI":"10.3390\/cells10102759"},{"key":"23626_CR35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich, L. & Tacke, F. Hepatic inflammatory responses in liver fibrosis. Nat. Rev. Gastroenterol. Hepatol. 20, 633\u2013646. https:\/\/doi.org\/10.1038\/s41575-023-00807-x (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"23626_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1039\/d4fo04271a","volume":"16","author":"C Anwar","year":"2025","unstructured":"Anwar, C., Chu, Y. C., Tsai, M. L., Ho, C. T. & Lai, C. S. Tetrahydrocurcumin alleviates di-(2-ethylhexyl) phthalate-induced adipose tissue dysfunction and testicular toxicity in adult mice: possible involvement of adiponectin-adipoR signaling in the testis. Food Funct. 16, 583\u2013600. https:\/\/doi.org\/10.1039\/d4fo04271a (2025).","journal-title":"Food Funct."},{"key":"23626_CR37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy, P. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch. Toxicol. 87, 1315\u20131530. https:\/\/doi.org\/10.1007\/s00204-013-1078-5 (2013).","journal-title":"Arch. Toxicol."},{"key":"23626_CR38","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","volume":"24","author":"M Ricchi","year":"2009","unstructured":"Ricchi, M. et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J. Gastroenterol. Hepatol. 24, 830\u2013840. https:\/\/doi.org\/10.1111\/j.1440-1746.2008.05733.x (2009).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"23626_CR39","doi-asserted-by":"publisher","unstructured":"Teixeira, F. S. et al. Differential lipid accumulation on HepG2 cells triggered by palmitic and Linoleic fatty acids exposure. Molecules 28 https:\/\/doi.org\/10.3390\/molecules28052367 (2023).","DOI":"10.3390\/molecules28052367"},{"key":"23626_CR40","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jfda.2018.01.005","volume":"26","author":"JW Chen","year":"2018","unstructured":"Chen, J. W. et al. Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells. J. Food Drug Anal. 26, 1075\u20131085. https:\/\/doi.org\/10.1016\/j.jfda.2018.01.005 (2018).","journal-title":"J. Food Drug Anal."},{"key":"23626_CR41","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10620-014-3167-6","volume":"59","author":"S Thapaliya","year":"2014","unstructured":"Thapaliya, S. et al. Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model. Dig. Dis. Sci. 59, 1197\u20131206. https:\/\/doi.org\/10.1007\/s10620-014-3167-6 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"23626_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/cdd.2009.124","volume":"17","author":"P Laplante","year":"2010","unstructured":"Laplante, P. et al. Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis. Cell. Death Differ. 17, 291\u2013303. https:\/\/doi.org\/10.1038\/cdd.2009.124 (2010).","journal-title":"Cell. Death Differ."},{"key":"23626_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021 (2017).","journal-title":"Cell"},{"key":"23626_CR44","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660\u2013665. https:\/\/doi.org\/10.1038\/nature15514 (2015).","journal-title":"Nature"},{"key":"23626_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3727\/105221617X15093707969658","volume":"18","author":"K Stephenson","year":"2018","unstructured":"Stephenson, K. et al. Updates on dietary models of nonalcoholic fatty liver disease: current studies and insights. Gene Expr. 18, 5\u201317. https:\/\/doi.org\/10.3727\/105221617X15093707969658 (2018).","journal-title":"Gene Expr"},{"key":"23626_CR46","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1139\/o90-079","volume":"68","author":"ZM Yao","year":"1990","unstructured":"Yao, Z. M. & Vance, D. E. Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem. Cell. Biol. 68, 552\u2013558. https:\/\/doi.org\/10.1139\/o90-079 (1990).","journal-title":"Biochem. Cell. Biol."},{"key":"23626_CR47","doi-asserted-by":"publisher","first-page":"101728","DOI":"10.1016\/j.molmet.2023.101728","volume":"73","author":"G Mocciaro","year":"2023","unstructured":"Mocciaro, G. et al. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Mol. Metab. 73, 101728. https:\/\/doi.org\/10.1016\/j.molmet.2023.101728 (2023).","journal-title":"Mol. Metab."},{"key":"23626_CR48","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1124\/dmd.109.027466","volume":"37","author":"CD Fisher","year":"2009","unstructured":"Fisher, C. D. et al. Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug Metab. Dispos. 37, 2087\u20132094. https:\/\/doi.org\/10.1124\/dmd.109.027466 (2009).","journal-title":"Drug Metab. Dispos."},{"key":"23626_CR49","doi-asserted-by":"publisher","unstructured":"Novaes, J. T. et al. Disposition, metabolism and histone deacetylase and acetyltransferase Inhibition activity of Tetrahydrocurcumin and other curcuminoids. Pharmaceutics 9 https:\/\/doi.org\/10.3390\/pharmaceutics9040045 (2017).","DOI":"10.3390\/pharmaceutics9040045"},{"key":"23626_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3803\/EnM.2021.1305","volume":"37","author":"KB Ha","year":"2022","unstructured":"Ha, K. B. et al. EW-7197 attenuates the progression of diabetic nephropathy in db\/db mice through suppression of fibrogenesis and inflammation. Endocrinol. Metab. (Seoul). 37, 96\u2013111. https:\/\/doi.org\/10.3803\/EnM.2021.1305 (2022).","journal-title":"Endocrinol. Metab. (Seoul)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23626-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:28:07Z","timestamp":1763134087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23626-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23626"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23626-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39936"}}